ATHEROSCLEROTIC cardiovascular complications are the leading cause of. Diabetes Mellitus Has an Additional Effect on Coronary Artery Disease

Size: px
Start display at page:

Download "ATHEROSCLEROTIC cardiovascular complications are the leading cause of. Diabetes Mellitus Has an Additional Effect on Coronary Artery Disease"

Transcription

1 Diabetes Mellitus Has an Additional Effect on Coronary Artery Disease To Decrease Plasma Adiponectin Levels Kuei-Chuan CHAN, 1 MD, Hsi-Hsien CHOU, 1 PhD, Der-Jinn WU, 1 PhD, Yi-Liang WU, 1 MD, and Chien-Ning HUANG, 1 MD SUMMARY We investigated whether plasma levels of adiponectin in patients with both coronary artery disease (CAD) and diabetes mellitus (DM) are lower than in patients with CAD alone. We examined plasma adiponectin levels in 113 patients, 82 with CAD (40 of whom had both CAD and type 2 DM) and 31 normal controls. We found differences in plasma adiponectin levels between CAD patients with and without DM (7.8 ± 4.75 versus 12.1 ± 6.87 µg/ml, P = 0.002), between patients with CAD and controls (10.0 ± 6.27 versus 15.3 ± 5.38 µg/ml, P ), and between men and women (10.2 ± 6.41 versus 13.1 ± 6.22 µg/ml, P = 0.017). Plasma adiponectin levels were correlated negatively with body mass index, triglyceride, total cholesterol, hemoglobin A1c, and fibrinogen levels (r = , P ; r = , P ; r = , P = 0.002; r = , P < ; r = , P, respectively), but were not significantly correlated with high sensitivity C-reactive protein or low density lipoprotein levels (r = , P = 0.352; r = , P = 0.077, respectively). Plasma adiponectin levels correlated positively with high density lipoprotein levels (r = 0.410, P ). Our study demonstrates that plasma adiponectin levels in patients with both CAD and DM are lower than in patients with CAD alone. We speculate that people who have very low plasma adiponectin levels may be at increased risk of developing both CAD and DM. (Jpn Heart J 2004; 45: ) Key words: Adiponectin, Coronary artery disease, Diabetes mellitus ATHEROSCLEROTIC cardiovascular complications are the leading cause of mortality and morbidity among patients with type 2 diabetes. The precise mechanism underlying the development of atherosclerotic vascular disease in diabetic patients has not been fully clarified. Insulin resistance, abnormalities in lipid metabolism and hemostatic factors may contribute to the development of cardiovascular complications in diabetes. 1) It was found recently that adipose tissue is From the 1 Department of Internal Medicine, Institute of Medicine, Chung-Shan Medical University Hospital, Taichung, Taiwan. Address for correspondence: Chien-Ning Huang, MD, Department of Internal Medicine, Chung-Shan Medical University Hospital, No. 110, Sec. 1, Chien-Kuo N. Road, Taichung 402, Taiwan. Received for publication March 30, Revised and accepted May 31,

2 922 CHAN, ET AL Jpn Heart J November 2004 not only an energy storage organ, but also plays an important role in the development of obesity-related disease, including insulin resistance, diabetes mellitus (DM), hyperlipidemia, and vascular diseases through the secretion of various bioactive substances conceptualized as adipocytokines. 2,3) Adiponectin, a 244-amino acid adipocyte-derived protein, accounting for approximately 0.01% of total plasma protein and with concentrations ranging between 4.8 and 34.7µg/mL, was recently revealed to have anti-inflammatory, antidiabetic, and antiatherogenic properties. 4-13) Plasma adiponectin concentrations were found to decrease in individuals with obesity, type 2 DM, and CAD, while an improvement of insulin sensitivity by either weight reduction 8) or administration of thiazolidinediones was associated with increased adiponectin concentrations ) Adiponectin levels have also been found to be lower in adult men than women, and downregulation of adiponectin by androgens, which has been observed in animal models, may explain these differences. 7) People who have high plasma adiponectin concentrations are less likely to develop type 2 diabetes than those with low concentrations. 11,12) It has been reported that plasma levels of adiponectin in diabetic patients with CAD were lower than those in diabetic patients without CAD. 1) That is to say, decreased plasma adiponectin concentrations in diabetes may be an indicator of CAD. However, it also has been reported that the differences in the adiponectin levels between CAD patients with and without DM were relatively small. 17) In this study, we investigated the differences in plasma adiponectin levels between CAD patients with and without DM to determine if they are similar or different. METHODS Patient groups: One hundred and thirteen Taiwanese patients (63 males and 50 females, age range, 23 to 83 years) were recruited in this study. Of these 113 patients, 82 had coronary artery disease (40 had both coronary artery disease and type 2 diabetes mellitus). As a control group, 31 patients without coronary artery disease or diabetes mellitus were included. The criteria for coronary artery disease were 75% or greater stenosis of at least 1 segment of a major coronary artery confirmed by quantitative coronary angiography by perpendicular projections. Diagnosis of diabetes mellitus was in accordance with the criteria adapted from the American Diabetes Association, Patients who took any antihyperlipidemic drugs, antibiotics, or thiazolidinediones were excluded. Informed consent was obtained from all subjects. Blood sampling and measurement of adiponectin: Blood samples from coronary artery disease patients were obtained after an overnight fast and immediately after coronary intervention. Blood samples for the measurement of fasting plasma adi-

3 Vol 45 No 6 ADIPONECTIN AND DIABETIC CORONARY ARTERY DISEASE 923 ponectin concentrations were drawn into prechilled EDTA-containing tubes and immediately placed on ice. All tubes were centrifuged within several minutes of collection and stored at -70 C until assay. Fasting plasma adiponectin concentrations were measured using a radioimmunoassay kit specific for human adiponectin (HADP-61 HK; LINCO Research, St. Charles, Missouri, USA) after 1:500 dilution. Samples were analysed in two batches, with an intra-assay coefficient of variation (CV) < 5% and inter-assay CV < 8% for duplicates over a range of adiponectin concentrations. Statistical analysis: A commercially available software package (Statistical Package for Social Sciences, SPSS 10.0, for Windows) was used for analyzing the data, which is presented as the mean ± standard deviation. The statistical significance of intergroup differences was analyzed by the chi-square test and by Student s t test. ANOVA analysis was used to compare differences in continuous variables between more than two groups. Correlations between 2 parameters were determined by the Pearson correlation coefficient. A P < 0.05 was considered statistically significant. RESULTS The demographic data for the study patients are presented in Table I. One hundred and thirteen patients, 82 with CAD (40 of whom had both CAD and type 2 DM) and 31 normal controls, were enrolled in the study. Patients with both CAD and DM had the highest BMI, hs-crp, triglyceride, total cholesterol, hemoglobin A1c and fibrinogen levels, and the lowest levels of adiponectin and high Table I. Demographic Data Variable CAD (+)/DM (+) (n = 40) CAD (+)/DM (-) (n = 42) Control (n = 31) P-value (ANOVA) Age (years) Gender (male) BMI (kg/m 2 ) Adiponectin level (µg/ml) hs-crp (mg/l) Triglycerides (mg/dl) Total cholesterol (mg/dl) High density lipoprotein (mg/dl) Low density lipoprotein (mg/dl) Hemoglobin A1c (%) Fibrinogen (mg/dl) 61.7 ± (55.0%) 25.9 ± ± ± ± ± ± ± ± ± ± (71.4%) 25.0 ± ± ± ± ± ± ± ± ± ± (35.5%) 21.9 ± ± ± ± ± ± ± ± ± * 0.009* 0.007* Data are mean ± standard deviation. CAD (+) = patients with coronary artery disease; DM (+) = patients with diabetes mellitus; DM (-) = patients without diabetes mellitus; BMI = body mass index; hs-crp = high sensitivity C-reactive protein.

4 924 CHAN, ET AL Jpn Heart J November 2004 density lipoprotein. The BMI values for CAD with and without DM were similar. As shown in Table II, there were statistically significant differences in adiponectin levels between the patients with both CAD and DM and the patients with CAD alone (7.8 ± 4.75 versus 12.1 ± 6.87 µg/ml, P = 0.002), between patients with CAD and normal controls (10.0 ± 6.27 versus 15.3 ± 5.38 µg/ml, P ), and between males and females (10.2 ± 6.41 versus 13.1 ± 6.22 µg/ml, P = 0.017). Table III shows that there were significant negative correlations between (a) the adiponectin level and (b) body mass index, triglyceride, total cholesterol, hemoglobin A1c, and fibrinogen levels (r = , P ; r = , P < ; r = , P = 0.002; r = , P ; r = , P, respectively), but there were no significant negative correlations between the adiponectin level and high sensitivity C-reactive protein or low density lipoprotein level (r = , P = 0.352; r = , P = 0.077, respectively). There was a positive correlation between adiponectin levels and high density lipoprotein levels (r = 0.410, P ). As shown in Table IV, compared with normal controls, patients with CAD have higher BMIs and higher levels of high sensitivity C-reactive protein, triglycerides, total cholesterol, hemoglobin A1c, and fibrinogen. Table II. Differences in Adiponectin Levels Between Subgroups CAD (+), DM (+) (n = 40) CAD (+), DM (-) (n = 42) CAD (+) (n = 82) Normal controls (n = 31) Male (n = 63) Female (n = 50) Adiponectin 7.8 ± ± ± ± ± ± 6.22 P-value 0.002* 0.017* Table III. Correlations Between Adiponectin Level and Other Cardiovascular Risk Factors BMI (kg/m 2 ) hs-crp (mg/l) Triglycerides (mg/dl) Total cholesterol (mg/dl) High density lipoprotein (mg/dl) Low density lipoprotein (mg/dl) Hemoglobin A1c (%) Fibrinogen (mg/dl) Pearson ** ** ** 0.410** ** ** P-value

5 Vol 45 No 6 ADIPONECTIN AND DIABETIC CORONARY ARTERY DISEASE 925 Table IV. Differences Between CAD Patients and Normal Controls Variable CAD (+) (n = 82) Normal Controls (n = 31) P value Gender (male) BMI (kg/m 2 ) Adiponectin (µg/ml) hs-crp (mg/l) Triglycerides (mg/dl) Total cholesterol (mg/dl) High density lipoprotein (mg/dl) Low density lipoprotein (mg/dl) Hemoglobin A1c (%) Fibrinogen (mg/dl) 52 (63.4%) 25.4 ± ± ± ± ± ± ± ± ± (35.5%) 21.8 ± ± ± ± ± ± ± ± ± * 0.014* 0.001* 0.002* However, these patients have lower levels of adiponectin and high density lipoprotein. DISCUSSION Plasma adiponectin accumulates in the vascular wall when the endothelial barrier is injured. 18) It has also been reported that adiponectin inhibits monocyte adhesion to endothelial cells and macrophage-to-foam cell transformation, and attenuates TNF-α-induced expression of adhesion molecules in endothelial cells, which is the initial step of atherosclerosis. 1,5,8,9) This study has demonstrated that plasma adiponectin levels in patients with both CAD and DM are lower than in patients with CAD alone and that plasma levels of adiponectin are also associated with some coronary risk factors in patients with CAD. Previous studies showed that adiponectin levels were associated with gender, BMI, CAD, DM, insulin resistance, triglyceride levels, low density lipoprotein (LDL) levels, high density lipoprotein (HDL) levels, 1-3,5-13) and high sensitivity C-reactive protein (hs-crp) levels. 19) In our study, the levels of adiponectin were significantly correlated with gender, BMI, triglyceride levels, total cholesterol levels, HDL levels, fibrinogen levels, and hemoglobin A1c levels, but not significantly correlated with hs-crp or low density lipoprotein levels. Fibrinogen levels have been found to have a significant association with premature CAD. The mechanism by which fibrinogen promotes CAD is not well understood but may involve, at least in part, its effects on plasma viscosity. 20) The percent of glycated hemoglobin (hemoglobin A1c) gives an estimate of blood sugar control for the preceding 3-month period. In our study, we found that plasma levels of adiponectin were correlated negatively and significantly with hemoglobin A1c

6 926 CHAN, ET AL Jpn Heart J November 2004 levels. This suggests that patients who have poor glycemic control will have lower plasma adiponectin levels than those with good glycemic control. Our study included only a small sample size, and larger sample sizes in further studies are needed. Although the small sample size does not enable us to make a definitive conclusion, ours is the first study to reveal that there are significant differences in plasma levels of adiponectin between CAD patients with and without DM. DM has an additional effect on CAD, that of decreasing plasma adiponectin levels. We speculate that people who have very low plasma adiponectin levels may be at increased risk of developing both CAD and DM. ACKNOWLEDGEMENTS This work was supported by a research fund from Chung Shan Medical University (CSMC 87-OM-B-041) to Chien-Ning Huang. REFERENCES 1. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: Stefan N, Stumvoll M. Adiponectin - its role in metabolism and beyond. Horm Metab Res 2002; 34: (Review) 3. Yamamoto Y, Hirose H, Saito I, Nishikai K, Saruta T. Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population. J Clin Endocrinol Metab 2004; 89: Lindsay RS, Walker JD, Havel PJ, et al. Adiponectin is present in cord blood but is unrelated to birth weight. Diabetes Care 2003; 26: Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: Zoccali C, Mallamaci F, Tripepi G, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: Nishizawa H, Shimomura I, Kishida K, et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002; 51: Yang WS, Lee WJ, Funahashi T, et al. Weight reduction increases plasma levels of an adipose-derived antiinflammatory protein, adiponectin. J Clin Endocrinol Metab 2001; 86: Kumada M, Kihara S, Sumitsuji S, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23: Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: Spranger J, Kroke A, Mohlig M, et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003; 361: Lindsay RS, Funahashi T, Hanson RL, et al. Adiponectin and development of type 2 diabetes in the Pima India population. Lancet 2002; 360: Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: Maeda N, Takahashi M, Funahashi T, et al. PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001; 50:

7 Vol 45 No 6 ADIPONECTIN AND DIABETIC CORONARY ARTERY DISEASE Yang WS, Jeng CY, Wu TJ, et al. Synthetic peroxisome proliferator-activated receptor-γ agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care 2002, 25: Hirose H, Kawai T, Yamamoto Y, et al. Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes. Metabolism 2002; 51: Shimada K, Miyauchi K, Mokuno H, et al. Predictive value of the adipocyte-derived plasma protein adiponectin for restenosis after elective coronary stenting. Jpn Heart J 2002; 43: Okamoto Y, Arita Y, Nishida M, et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular wall. Horm Metab Res 2000; 32: Ouchi N, Kihara S, Funahashi T, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003; 107: Rader DJ. Textbook of Cardiovascular Medicine. 2 nd. In: Lipid Disorders, ed. Lippincott. Philadelphia: Williams & Wilkins; 2002: 66.

Atherosclerotic diseases are the leading cause of death in

Atherosclerotic diseases are the leading cause of death in Adiponectin and Metabolic Syndrome Yuji Matsuzawa, Tohru Funahashi, Shinji Kihara, Iichiro Shimomura Abstract In this review article, the crucial roles of adipocytes in the development of so-called metabolic

More information

Changes and clinical significance of serum vaspin levels in patients with type 2 diabetes

Changes and clinical significance of serum vaspin levels in patients with type 2 diabetes Changes and clinical significance of serum vaspin levels in patients with type 2 diabetes L. Yang*, S.J. Chen*, G.Y. Yuan, D. Wang and J.J. Chen Department of Endocrinology, Affiliated Hospital of Jiangsu

More information

Plasma Levels of Adiponectin, a Novel Adipocyte-Derived Hormone, in Sleep Apnea

Plasma Levels of Adiponectin, a Novel Adipocyte-Derived Hormone, in Sleep Apnea Plasma Levels of Adiponectin, a Novel Adipocyte-Derived Hormone, in Sleep Apnea Robert Wolk, Anna Svatikova, Christy A. Nelson, Apoor S. Gami, Kogilan Govender, Mikolaj Winnicki, and Virend K. Somers Abstract

More information

The metabolic syndrome and adipocytokines

The metabolic syndrome and adipocytokines FEBS Letters 580 (2006) 2917 2921 Minireview The metabolic syndrome and adipocytokines Yuji Matsuzawa * Sumitomo Hospital, Professor Emeritus Osaka University, 5-3-20 Nakanoshima, Kita-Ku, Osaka 530-0005,

More information

A diponectin is a collagen-like plasma protein produced

A diponectin is a collagen-like plasma protein produced 528 CARDIOVASCULAR MEDICINE Implications of plasma concentrations of adiponectin in patients with coronary artery disease Y Nakamura, K Shimada, D Fukuda, Y Shimada, S Ehara, M Hirose, T Kataoka, K Kamimori,

More information

Effect of adiponectin on carotid arterial stiffness in type 2 diabetic patients treated with pioglitazone and metformin

Effect of adiponectin on carotid arterial stiffness in type 2 diabetic patients treated with pioglitazone and metformin Metabolism Clinical and Experimental 55 (2006) 996 1001 www.elsevier.com/locate/metabol Effect of adiponectin on carotid arterial stiffness in type 2 diabetic patients treated with pioglitazone and metformin

More information

Association of Insulin Resistance and Selected Adipokines in Cardiovascular Disease with and without Metabolic Syndrome

Association of Insulin Resistance and Selected Adipokines in Cardiovascular Disease with and without Metabolic Syndrome JMSCR Volume 2 Issue Pages 11-11 May www.jmscr.igmpublication.org Impact Factor-1.114 ISSN (e)-234-1x Association of Insulin Resistance and Selected Adipokines in Cardiovascular Disease with and without

More information

Type 2 diabetes mellitus is associated with lower serum adiponectin level in Bangladeshi population Abstract

Type 2 diabetes mellitus is associated with lower serum adiponectin level in Bangladeshi population Abstract 16 Mediscope 2015;2(2):16-21 www.gmc.edu.bd ISSN: 2307-7689 Mediscope The Journal of GMC ORIGINAL ARTICLE Type 2 diabetes mellitus is associated with lower serum adiponectin level in Bangladeshi population

More information

Obesity, defined as excess fat accumulation, is the most

Obesity, defined as excess fat accumulation, is the most Association of Hypoadiponectinemia With Coronary Artery Disease in Men Masahiro Kumada, Shinji Kihara, Satoru Sumitsuji, Toshiharu Kawamoto, Satoru Matsumoto, Noriyuki Ouchi, Yukio Arita, Yoshihisa Okamoto,

More information

and Restenosis Yangsoo Jang, MD, PhD. Yonsei University College of Medicine

and Restenosis Yangsoo Jang, MD, PhD. Yonsei University College of Medicine PPAR- Agonist and In-Stent Restenosis Yangsoo Jang, MD, PhD. Yonsei University College of Medicine Peroxisome Proliferator- activated Receptors (PPAR) Lipid-activated transcription factors : => regulating

More information

Decrease in Plasma Adiponectin Concentrations in Patients With Variant Angina Pectoris

Decrease in Plasma Adiponectin Concentrations in Patients With Variant Angina Pectoris Circ J 2006; 70: 414 418 Decrease in Plasma Adiponectin Concentrations in Patients With Variant Angina Pectoris Soon Jun Hong, MD; Hong Seog Seo, MD; Seung Woon Rha, MD; Dong Joo Oh, MD; Jung Ah Kwon,

More information

Relationship to visceral adiposity, insulin sensitivity, and -cell function

Relationship to visceral adiposity, insulin sensitivity, and -cell function Metabolic Syndrome/Insulin Resistance Syndrome/Pre-Diabetes O R I G I N A L A R T I C L E Adiponectin in Youth Relationship to visceral adiposity, insulin sensitivity, and -cell function FIDA BACHA, MD

More information

Associations among Lifestyle Status, Serum Adiponectin Level and Insulin Resistance

Associations among Lifestyle Status, Serum Adiponectin Level and Insulin Resistance ORIGINAL ARTICLE Associations among Lifestyle Status, Serum Adiponectin Level and Insulin Resistance Hirokazu YOKOYAMA, Hiroshi HIROSE, Hideki OHGO* and Ikuo SAITO Abstract Objective The aim of this study

More information

Fat Accumulation and Obesity-related Cardiovascular Risk Factors in Middle-aged Japanese Men and Women

Fat Accumulation and Obesity-related Cardiovascular Risk Factors in Middle-aged Japanese Men and Women ORIGINAL ARTICLE Fat Accumulation and Obesity-related Cardiovascular Risk Factors in Middle-aged Japanese Men and Women Miwa Ryo 1, Tohru Funahashi 1, Tadashi Nakamura 1, Shinji Kihara 1, Kazuaki Kotani

More information

Adiponectin is independently associated with glycosylated haemoglobin

Adiponectin is independently associated with glycosylated haemoglobin European Journal of Endocrinology (2004) 150 201 205 ISSN 0804-4643 CLINICAL STUDY Adiponectin is independently associated with glycosylated haemoglobin José Manuel Fernández-Real, Patricia Botas-Cervero

More information

Adiponectin plasma concentration, type 2 diabetes mellitus, cardiovascular diseases and features of metabolic syndrome

Adiponectin plasma concentration, type 2 diabetes mellitus, cardiovascular diseases and features of metabolic syndrome Monika Żurawska-Kliś 1, Jacek Kasznicki 1, Marcin Kosmalski 1, Janusz Śmigielski 2, Józef Drzewoski 1 ORIGINAL 1 Department of Internal Medicine, Diabetology and Clinical Pharmacology, Medical University

More information

OBESITY IS COMMONLY associated with insulin resistance

OBESITY IS COMMONLY associated with insulin resistance 0021-972X/01/$03.00/0 Vol. 86, No. 5 The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close

More information

Effect of Fenofibrate on Adiponectin and Inflammatory Biomarkers in Metabolic Syndrome Patients

Effect of Fenofibrate on Adiponectin and Inflammatory Biomarkers in Metabolic Syndrome Patients nature publishing group Effect of Fenofibrate on Adiponectin and Inflammatory Biomarkers in Metabolic Syndrome Patients Robert S. Rosenson 1 Adiponectin is an adipose-secreted hormone with anti-inflammatory

More information

DECLARATION OF CONFLICT OF INTEREST. None

DECLARATION OF CONFLICT OF INTEREST. None DECLARATION OF CONFLICT OF INTEREST None BURDEN OF CORONARY ARTERY DISEASE IN DIABETES IN INDIA Amal Kumar Banerjee MD, DM,FACC,FESC,FACP,FAPSC,FICC President Association of Physicians of India SAARC Cardiac

More information

A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus

A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus Original Research Article A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus Deepa Kalikavil Puthenveedu 1, Sundaraj

More information

Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms

Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms QQ QR/RR n = 36 n = 80 Men (%) 20 (55) 54 (67) 0.216 Age (years) 57 ± 10 56 ±

More information

Decreased Serum Levels of Adiponectin Are a Risk Factor for the Progression to Type 2 Diabetes in the Japanese Population

Decreased Serum Levels of Adiponectin Are a Risk Factor for the Progression to Type 2 Diabetes in the Japanese Population Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Decreased Serum Levels of Adiponectin Are a Risk Factor for the Progression to Type 2 Diabetes in the Japanese Population

More information

Plasma Adiponectin and Insulin Resistance in Korean Type 2 Diabetes Mellitus

Plasma Adiponectin and Insulin Resistance in Korean Type 2 Diabetes Mellitus Yonsei Medical Journal Vol. 46, No. 1, pp. 42-50, 2005 Plasma Adiponectin and Insulin Resistance in Korean Type 2 Diabetes Mellitus Mi-Jin Kim 1, Kwang-Ha Yoo 1, Hyung-Suk Park 1, Sang-Man Chung 1, Choon-Jo

More information

Adiponectin is an adipose tissuespecific

Adiponectin is an adipose tissuespecific Pathophysiology/Complications O R I G I N A L A R T I C L E Synthetic Peroxisome Proliferator Activated Receptor- Agonist, Rosiglitazone, Increases Plasma Levels of Adiponectin in Type 2 Diabetic Patients

More information

Original Article Association of serum SPARC level with severity of coronary artery lesion in type 2 diabetic patients with coronary heart disease

Original Article Association of serum SPARC level with severity of coronary artery lesion in type 2 diabetic patients with coronary heart disease Int J Clin Exp Med 2015;8(10):19290-19296 www.ijcem.com /ISSN:1940-5901/IJCEM0011299 Original Article Association of serum SPARC level with severity of coronary artery lesion in type 2 diabetic patients

More information

International Journal of Health Sciences and Research ISSN:

International Journal of Health Sciences and Research   ISSN: International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Assessment of Serum Adiponectin and Lipid Parameters in Patients of Acute Myocardial Infarction

More information

Division of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, Japan

Division of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, Japan Association between continuously elevated C-reactive protein and restenosis after percutaneous coronary intervention using drug-eluting stent in angina patients Division of Cardiovascular Medicine, Jichi

More information

Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation

Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation European Journal of Endocrinology (2003) 148 657 662 ISSN 0804-4643 CLINICAL STUDY Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation Miyao Matsubara, Katsuhiko

More information

International Journal of Pure and Applied Sciences and Technology

International Journal of Pure and Applied Sciences and Technology Int. J. Pure Appl. Sci. Technol., 23(1) (2014), pp. 28-33 International Journal of Pure and Applied Sciences and Technology ISSN 2229-6107 Available online at www.ijopaasat.in Research Paper Evaluation

More information

The Role of Serum Adiponectin Concentration in Diabetic Patients with Diabetic Retinopathy

The Role of Serum Adiponectin Concentration in Diabetic Patients with Diabetic Retinopathy Australian Journal of Basic and Applied Sciences, (3): 535-539, 008 ISSN 1991-8178 The Role of Serum Adiponectin Concentration in Diabetic Patients with Diabetic Retinopathy 1 1 Sameha Abu EL-Yazid, Nagwa

More information

Fasting Insulin, Adiponectin, hs-crp Levels, and The Components of Metabolic Syndrome

Fasting Insulin, Adiponectin, hs-crp Levels, and The Components of Metabolic Syndrome ORIGINAL ARTICLE Fasting Insulin, Adiponectin, hs-crp Levels, and The Components of Metabolic Syndrome Fabiola MS Adam, Mario GB Nara, John MF Adam ABSTRACT Aim: in this study we report the relationship

More information

Adiponectin, TG/HDL-cholesterol index and hs-crp. Predictors of insulin resistance.

Adiponectin, TG/HDL-cholesterol index and hs-crp. Predictors of insulin resistance. ORIGINAL ARTICLE Adiponectin, TG/HDL-cholesterol index and hs-crp. Predictors of insulin resistance. Bonneau GA y Pedrozo WR 1 Ministry of Public Health, Province of Misiones, 2 School of Exact, Chemical

More information

Welcome and Introduction

Welcome and Introduction Welcome and Introduction This presentation will: Define obesity, prediabetes, and diabetes Discuss the diagnoses and management of obesity, prediabetes, and diabetes Explain the early risk factors for

More information

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients 2012 International Conference on Life Science and Engineering IPCBEE vol.45 (2012) (2012) IACSIT Press, Singapore DOI: 10.7763/IPCBEE. 2012. V45. 14 Impact of Physical Activity on Metabolic Change in Type

More information

Journal of the American College of Cardiology Vol. 48, No. 7, by the American College of Cardiology Foundation ISSN /06/$32.

Journal of the American College of Cardiology Vol. 48, No. 7, by the American College of Cardiology Foundation ISSN /06/$32. Journal of the American College of Cardiology Vol. 48, No. 7, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.06.053

More information

Study of the correlation between growth hormone deficiency and serum leptin, adiponectin, and visfatin levels in adults

Study of the correlation between growth hormone deficiency and serum leptin, adiponectin, and visfatin levels in adults Study of the correlation between growth hormone deficiency and serum leptin, adiponectin, and visfatin levels in adults Z.-P. Li 1, M. Zhang 2, J. Gao 3, G.-Y. Zhou 3, S.-Q. Li 1 and Z.-M. An 3 1 Golden

More information

Adipose Tissue as an Endocrine Organ. Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University

Adipose Tissue as an Endocrine Organ. Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University Adipose Tissue as an Endocrine Organ Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University Functions of Adipose Tissue Adipose tissue expresses and secretes a variety of bioactive peptides,

More information

The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India

The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India eissn: 09748369, www.biolmedonline.com The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India M Estari, AS Reddy, T Bikshapathi,

More information

Diabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome

Diabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome Diabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome John E. Nestler, M.D. William Branch Porter Professor of Medicine Chair, Department of Internal Medicine Virginia Commonwealth University

More information

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li

More information

The Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

The Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk Update 2013 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine Denver Health

More information

INCREASED SERUM HIGH-DENSITY LIPOPROTEIN CHOLESTEROL LEVEL IS ASSOCIATED WITH A REDUCTION IN PERIPHERAL MONOCYTE COUNT

INCREASED SERUM HIGH-DENSITY LIPOPROTEIN CHOLESTEROL LEVEL IS ASSOCIATED WITH A REDUCTION IN PERIPHERAL MONOCYTE COUNT INCREASED SERUM HIGH-DENSITY LIPOPROTEIN CHOLESTEROL LEVEL IS ASSOCIATED WITH A REDUCTION IN PERIPHERAL MONOCYTE COUNT IN NORMAL INDIVIDUALS Zei-Shung Huang, 1 Kwan-Lih Hsu, 1 Kuo-Liong Chien, 1 Tien-Chun

More information

Keywords: Type 2 DM, lipid profile, metformin, glimepiride ABSTRACT

Keywords: Type 2 DM, lipid profile, metformin, glimepiride ABSTRACT Human Journals Research Article September 2015 Vol.:4, Issue:2 All rights are reserved by K. Saravanan et al. Effects of Monotherapy and Combination Therapy Involving Metformin and Glimepiride on HbA1c

More information

Pathophysiology of Lipid Disorders

Pathophysiology of Lipid Disorders Pathophysiology of Lipid Disorders Henry Ginsberg, M.D. Division of Preventive Medicine and Nutrition CHD in the United States CHD is the single largest killer of men and women 12 million have history

More information

Serum Retinol-binding Protein 4 Levels in Patients with Diabetic Retinopathy

Serum Retinol-binding Protein 4 Levels in Patients with Diabetic Retinopathy The Journal of International Medical Research 2010; 38: 95 99 Serum Retinol-binding Protein 4 Levels in Patients with Diabetic Retinopathy Z-Z LI 1, X-Z LU 2, J-B LIU 1 AND L CHEN 1 1 Department of Endocrinology,

More information

Leptin deficiency suppresses progression of atherosclerosis in apoe-deficient mice

Leptin deficiency suppresses progression of atherosclerosis in apoe-deficient mice Leptin deficiency suppresses progression of atherosclerosis in apoe-deficient mice Atherosclerosis, 2007 Chiba T, Shinozaki S, Nakazawa T, et al. Present by Sudaporn Pummoung Apolipoprotein E (apoe( apoe)

More information

ADIPONECTIN -THE MOLECULE OF THIS DECADE

ADIPONECTIN -THE MOLECULE OF THIS DECADE 2 : 28 ADIPONECTIN -THE MOLECULE OF THIS DECADE Adipocyte as we knew all these days was considered as a mere organ for deposition of fat however this view now is no longer tenable. We now know that adipocytes

More information

7. EVIDENCE BASED LABORATORY MEDICINE IN THE DIAGNOSIS OF METABOLIC SYNDROME

7. EVIDENCE BASED LABORATORY MEDICINE IN THE DIAGNOSIS OF METABOLIC SYNDROME 7. EVIDENCE BASED LABORATORY MEDICINE IN THE DIAGNOSIS OF METABOLIC SYNDROME Ana Stavljenić Rukavin, Daria Pašalić Zagreb University School of Medicine, Croatia 1. Introduction Evidence based medicine

More information

Metabolic Syndrome. Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah

Metabolic Syndrome. Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah Metabolic Syndrome Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah Objectives Be able to outline the pathophysiology of the metabolic syndrome Be able to list diagnostic criteria for

More information

Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance

Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance European Journal of Endocrinology (2003) 149 331 335 ISSN 0804-4643 CLINICAL STUDY Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance Josef

More information

KEY COMPONENTS. Metabolic Risk Cardiovascular Risk Vascular Inflammation Markers

KEY COMPONENTS. Metabolic Risk Cardiovascular Risk Vascular Inflammation Markers CardioMetabolic Risk Poor blood sugar regulation and unhealthy triglyceride and lipoprotein levels often present long before the diagnosis of type 2 Diabetes. SpectraCell s CardioMetabolic and Pre-Diabetes

More information

Inflammation: Novel Target for Cardiovascular Risk Reduction

Inflammation: Novel Target for Cardiovascular Risk Reduction Inflammation: Novel Target for Cardiovascular Risk Reduction Andrew Zalewski, M.D. Thomas Jefferson University, Philadelphia GlaxoSmithKline, Philadelphia Why inflammation? Population-based studies: low

More information

Annals of RSCB Vol. XVI, Issue 1

Annals of RSCB Vol. XVI, Issue 1 THE STUDY OF PROTHROBOTIC STATE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CARDIOVASCULAR DISEASES Oana Bădulescu 1, Codruţa Bădescu 2, Manuela Ciocoiu 1, Magda Bădescu 1 1 DEPARTMENT OF PATHOPHYSIOLOGY;

More information

Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan. 4

Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan. 4 146 Journal of Atherosclerosis and Thrombosis Original Articles Vol. 11, No. 3 Clinical Features of Familial Hypercholesterolemia in Japan in a Database from 1996 1998 by the Research Committee of the

More information

Non-insulin treatment in Type 1 DM Sang Yong Kim

Non-insulin treatment in Type 1 DM Sang Yong Kim Non-insulin treatment in Type 1 DM Sang Yong Kim Chosun University Hospital Conflict of interest disclosure None Committee of Scientific Affairs Committee of Scientific Affairs Insulin therapy is the mainstay

More information

Cho et al., 2009 Journal of Cardiology (2009), 54:

Cho et al., 2009 Journal of Cardiology (2009), 54: Endothelial Dysfunction, Increased Carotid Artery Intima-media Thickness and Pulse Wave Velocity, and Increased Level of Inflammatory Markers are Associated with Variant Angina Cho et al., 2009 Journal

More information

902 Biomed Environ Sci, 2014; 27(11):

902 Biomed Environ Sci, 2014; 27(11): 902 Biomed Environ Sci, 2014; 27(11): 902-906 Letter to the Editor Curcuminoids Target Decreasing Serum Adipocyte-fatty Acid Binding Protein Levels in Their Glucose-lowering Effect in Patients with Type

More information

Association between arterial stiffness and cardiovascular risk factors in a pediatric population

Association between arterial stiffness and cardiovascular risk factors in a pediatric population + Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro

More information

The New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk

The New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk The New Gold Standard for Lipoprotein Analysis Advanced Testing for Cardiovascular Risk Evolution of Lipoprotein Testing The Lipid Panel Total Cholesterol = VLDL + LDL + HDL Evolution of Lipoprotein Testing

More information

USING NON -TRADITIONAL RISK MARKERS IN ASSESSING CV RISK

USING NON -TRADITIONAL RISK MARKERS IN ASSESSING CV RISK USING NON -TRADITIONAL RISK MARKERS IN ASSESSING CV RISK JAMES M FALKO MD PROFESSOR OF MEDICINE UNIVERSITY OF COLORADO Adapted from: Rader D. N Engl J Med. 2000 hs-crp (mg/l) 6 5 4 3 2 1 *p

More information

Hypertriglyceridemia and the Related Factors in Middle-aged Adults in Taiwan

Hypertriglyceridemia and the Related Factors in Middle-aged Adults in Taiwan 1 Hypertriglyceridemia and the Related Factors in Middle-aged Adults in Taiwan Cheng-Chieh Lin, Tsai-Chung Li 2, Shih-Wei Lai, Kim-Choy Ng 1, Kuo-Che Wang, Chiu-Shong Liu Department of Community Medicine,

More information

Frequency of Dyslipidemia and IHD in IGT Patients

Frequency of Dyslipidemia and IHD in IGT Patients Frequency of Dyslipidemia and IHD in IGT Patients *Islam MS, 1 Hossain MZ, 2 Talukder SK, 3 Elahi MM, 4 Mondal RN 5 Impaired glucose tolerance (IGT) is often associated with macrovascular complications.

More information

Supplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups

Supplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups Supplemental Table S1: Unadjusted and Adjusted Hazard Ratios for Diabetes Associated with Baseline Factors Considered in Model 3 SMART Participants Only Unadjusted Adjusted* Baseline p-value p-value Covariate

More information

CRP and fibrinogen imply clinical outcome of patients with type-2 diabetes. and coronary artery disease

CRP and fibrinogen imply clinical outcome of patients with type-2 diabetes. and coronary artery disease CRP and fibrinogen imply clinical outcome of patients with type-2 diabetes and coronary artery disease Marijan Bosevski 1, *, Golubinka Bosevska 1, Lily Stojanovska 2, Vasso Apostolopoulos 2, * 1 University

More information

Apelin and Visfatin Plasma Levels in Healthy Individuals With High Normal Blood Pressure

Apelin and Visfatin Plasma Levels in Healthy Individuals With High Normal Blood Pressure Apelin and Visfatin Plasma Levels in Healthy Individuals With High Normal Blood Pressure CI Liakos, 1 EA Sanidas, 1 DN Perrea, 1 V Gennimata, 1 V Chantziara, 1 CA Grassos, 2 N-A Viniou, 1 JD Barbetseas,

More information

Biostatistics and Epidemiology Step 1 Sample Questions Set 2. Diagnostic and Screening Tests

Biostatistics and Epidemiology Step 1 Sample Questions Set 2. Diagnostic and Screening Tests Biostatistics and Epidemiology Step 1 Sample Questions Set 2 Diagnostic and Screening Tests 1. A rare disorder of amino acid metabolism causes severe mental retardation if left untreated. If the disease

More information

An association between adipokines and insulin. Discrimination Between Obesity and Insulin Resistance in the Relationship With Adiponectin

An association between adipokines and insulin. Discrimination Between Obesity and Insulin Resistance in the Relationship With Adiponectin Discrimination Between Obesity and Insulin Resistance in the Relationship With Adiponectin Fahim Abbasi, 1 James W. Chu, 1 Cindy Lamendola, 1 Tracey McLaughlin, 1 John Hayden, 2 Gerald M. Reaven, 1 Peter

More information

Association of serum adipose triglyceride lipase levels with obesity and diabetes

Association of serum adipose triglyceride lipase levels with obesity and diabetes Association of serum adipose triglyceride lipase levels with obesity and diabetes L. Yang 1 *, S.J. Chen 1 *, G.Y. Yuan 1, L.B. Zhou 2, D. Wang 1, X.Z. Wang 1 and J.J. Chen 1 1 Department of Endocrinology,

More information

Atherosclerotic cardiovascular complications are the major

Atherosclerotic cardiovascular complications are the major lasma Concentrations of a Novel, Adipose-Specific rotein, Adiponectin, in Type 2 atients Kikuko Hotta, Tohru Funahashi, Yukio Arita, Masahiko Takahashi, Morihiro Matsuda, Yoshihisa Okamoto, Hiromi Iwahashi,

More information

Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease

Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease Kidney International, Vol. 66 (2004), pp. 46 50 HORMONE CYTOKINES SIGNALIN Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease ALICIA MARCHLEWSKA,PETER STENVINKEL,BENGT

More information

EFFECTS OF PPARγ LIGANDS ON ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASE

EFFECTS OF PPARγ LIGANDS ON ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASE EFFECTS OF PPARγ LIGANDS ON ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASE C. Fiévet and B. Staels, Institut Pasteur de Lille, Département d Athérosclérose, Lille, F- 59019 France, Inserm, U545, Lille, F-59019

More information

Possible Impairment of Transcardiac Utilization of Adiponectin in Patients With Type 2 Diabetes

Possible Impairment of Transcardiac Utilization of Adiponectin in Patients With Type 2 Diabetes Pathophysiology/Complications O R I G I N A L A R T I C L E Possible Impairment of Transcardiac Utilization of Adiponectin in Patients With Type 2 Diabetes MASATO FURUHASHI, MD 1,2 NOBUYUKI URA, MD 1 NORIHITO

More information

Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center

Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center Diabetes and Heart Disease Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center No conflicts of interest or financial relationships to disclose. 2 What s the problem??

More information

Copyright 2017 by Sea Courses Inc.

Copyright 2017 by Sea Courses Inc. Diabetes and Lipids Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or by any means graphic, electronic, or

More information

THE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES

THE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES Int. J. LifeSc. Bt & Pharm. Res. 2013 Varikasuvu Seshadri Reddy et al., 2013 Review Article ISSN 2250-3137 www.ijlbpr.com Vol. 2, No. 1, January 2013 2013 IJLBPR. All Rights Reserved THE EFFECT OF VITAMIN-C

More information

Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan 2

Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan 2 The Scientific World Journal Volume 2012, Article ID 392734, 5 pages doi:10.1100/2012/392734 The cientificworldjournal Research Article A Neutral Risk on the Development of New-Onset Diabetes Mellitus

More information

Adipose Tissue Dysfunction and Diabetic Cardiovascular Disease

Adipose Tissue Dysfunction and Diabetic Cardiovascular Disease Adipose Tissue Dysfunction and Diabetic Cardiovascular Disease Xin-Liang Ma, MD, PhD Thomas Jefferson University Philadelphia, PA USA CVD As The #1 Causes of Death In USA Male Female Heart Disease and

More information

Adiponectin as a Potential Differential Marker to Distinguish Pancreatic Cancer and Chronic Pancreatitis

Adiponectin as a Potential Differential Marker to Distinguish Pancreatic Cancer and Chronic Pancreatitis ORIGINAL ARTICLE Adiponectin as a Potential Differential Marker to Distinguish Pancreatic Cancer and Chronic Pancreatitis Ming-Chu Chang, MD,* Yu-Ting Chang, MD, MS,* Ta-Chen Su, MD, PhD,*Þ Wei-Shiung

More information

Acarbose Decreases the Rheumatoid Arthritis Risk of Diabetic Patients and. Attenuates the Incidence and Severity of Collagen-induced Arthritis in Mice

Acarbose Decreases the Rheumatoid Arthritis Risk of Diabetic Patients and. Attenuates the Incidence and Severity of Collagen-induced Arthritis in Mice Acarbose Decreases the Rheumatoid Arthritis Risk of Diabetic Patients and Attenuates the Incidence and Severity of Collagen-induced Arthritis in Mice Authors: Chi-Chen Lin, Der-Yuan Chen, Ya-Hsuan Chao,

More information

The Egyptian Journal of Hospital Medicine (July 2017) Vol.68 (3), Page

The Egyptian Journal of Hospital Medicine (July 2017) Vol.68 (3), Page The Egyptian Journal of Hospital Medicine (July 2017) Vol.68 (3), Page 1505-1512 Assessment of Serum Levels in Patients with Acne Vulgaris Hanan M Saleh a, Manal A Sharara b, Mohamed A Habib c Department

More information

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study

JUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study Panel Discussion: Literature that Should Have an Impact on our Practice: The Study Kaiser COAST 11 th Annual Conference Maui, August 2009 Robert Blumberg, MD, FACC Ralph Brindis, MD, MPH, FACC Primary

More information

The changes of serum BDNF, blood lipid and PCI in the elderly patients with coronary heart disease complicated with diabetes mellitus

The changes of serum BDNF, blood lipid and PCI in the elderly patients with coronary heart disease complicated with diabetes mellitus 184 Journal of Hainan Medical University 2016; 22(16): 184-188 Journal of Hainan Medical University http://www.hnykdxxb.com/ The changes of serum BDNF, blood lipid and PCI in the elderly patients with

More information

Metabolic Syndrome. DOPE amines COGS 163

Metabolic Syndrome. DOPE amines COGS 163 Metabolic Syndrome DOPE amines COGS 163 Overview - M etabolic Syndrome - General definition and criteria - Importance of diagnosis - Glucose Homeostasis - Type 2 Diabetes Mellitus - Insulin Resistance

More information

Low Plasma Adiponectin Levels Predict Progression of Coronary Artery Calcification

Low Plasma Adiponectin Levels Predict Progression of Coronary Artery Calcification Low Plasma Adiponectin Levels Predict Progression of Coronary Artery Calcification David M. Maahs, MD; Lorraine G. Ogden, PhD; Gregory L. Kinney, MPH; Paul Wadwa, MD; Janet K. Snell-Bergeon, MPH; Dana

More information

Insulin Tolerance Test Predicts the Effectiveness of Insulin Sensitizers in Japanese Type 2 Diabetic Patients

Insulin Tolerance Test Predicts the Effectiveness of Insulin Sensitizers in Japanese Type 2 Diabetic Patients Diabetes Ther (2010) 1(2):121-130. DOI 10.1007/s13300-010-0011-7 ORIGINAL RESEARCH Insulin Tolerance Test Predicts the Effectiveness of Insulin Sensitizers in Japanese Type 2 Diabetic Patients Junji Kozawa

More information

Cardiovascular Complications of Diabetes

Cardiovascular Complications of Diabetes VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary

More information

( 1) Framingham Heart

( 1) Framingham Heart ( 1) ( 1) Framingham Heart Study [1] 1. (Am J Kidney Dis. 45: 223-232, 2005) 96 19 1 17 Framingham Heart Study ( 1) American Heart Association (1) (2) (3) (4) [2] (GFR) [3] ARIC [4] Cardiovascular Health

More information

Role of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD

Role of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD Role of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD Our laboratory focuses on the role of apolipoprotein (apo) B- containing lipoproteins in normal

More information

INTRODUCTION. Key Words:

INTRODUCTION. Key Words: Original Article Acta Cardiol Sin 2014;30:204 214 Metabolic Syndrome Leptin-to-Adiponectin Ratio is Related to Low Grade Inflammation and Insulin Resistance Independent of Obesity in Non-Diabetic Taiwanese:

More information

A study of waist hip ratio in identifying cardiovascular risk factors at Government Dharmapuri College Hospital

A study of waist hip ratio in identifying cardiovascular risk factors at Government Dharmapuri College Hospital Original Research Article A study of waist hip ratio in identifying cardiovascular risk factors at Government Dharmapuri College Hospital M. Arivumani * Assistant Professor of General Medicine, Government

More information

Plaque sample Saliva sample Treatment recommended

Plaque sample Saliva sample Treatment recommended ผศ.ทพ.ส พจน ตามสายลม ภาคว ชาปร ท นตว ทยา คณะท นตแพทยศาสตร จ ฬาลงกรณ มหาว ทยาล ย Oral health and Systemic health connection Several epidemiological and clinical studies have revealed significant associations

More information

Metformin. Sulfonylurea. Thiazolidinedione. Insulin

Metformin. Sulfonylurea. Thiazolidinedione. Insulin 동아의대내분비내과박미경 Metformin Sulfonylurea Thiazolidinedione Insulin 요약 markers of inflammation (hs-crp, TNF-a) markers of impaired endothelial function (VFW, scams, tpa, PAI-1) LDL-C, fasting and postprandial

More information

Fasting Serum Level of Fatty-Acid-Binding Protein 4 Positively Correlates With Metabolic Syndrome in Patients With Coronary Artery Disease

Fasting Serum Level of Fatty-Acid-Binding Protein 4 Positively Correlates With Metabolic Syndrome in Patients With Coronary Artery Disease Circulation Journal Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp Fasting Serum Level of Fatty-Acid-Binding Protein 4 Positively Correlates With Metabolic Syndrome in Patients

More information

Therapeutic effect of flavonoid rich extract of apricots on high-fat diet induced hyperlipidemia in rabbits

Therapeutic effect of flavonoid rich extract of apricots on high-fat diet induced hyperlipidemia in rabbits Therapeutic effect of flavonoid rich extract of apricots on high-fat diet induced hyperlipidemia in rabbits in rabbits TOOBA LATEEF Assistant Professor Department of Biochemistry Jinnah University for

More information

Andrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University

Andrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University CARDIOVASCULAR RISK FACTORS ORIGINAL ARTICLE Do We Correctly Assess the Risk of Cardiovascular Disease? Characteristics of Risk Factors for Cardiovascular Disease Depending on the Sex and Age of Patients

More information

Review Establishment of a concept of visceral fat syndrome and discovery of adiponectin

Review Establishment of a concept of visceral fat syndrome and discovery of adiponectin No. 2] Proc. Jpn. Acad., Ser. B 86 (2010) 131 Review Establishment of a concept of visceral fat syndrome and discovery of adiponectin By Yuji MATSUZAWA 1,2, (Communicated by Hiroo IMURA, M.J.A.) Abstract:

More information

Novel Markers of Arterial Dysfunction

Novel Markers of Arterial Dysfunction 혈관연구회창립심포지움, 3 월 3 일, 2005 Novel Markers of Arterial Dysfunction Kwang Kon Koh, MD, FACC, FAHA Cardiology Gachon Medical School Incheon, Korea Atherosclerosis: A progressive process PHASE I: Initiation

More information

Adiponectin in coronary heart disease and newly diagnosed impaired glucose tolerance

Adiponectin in coronary heart disease and newly diagnosed impaired glucose tolerance 0179DVR10510.1177/1479164113490179Diabetes & Vascular Disease ResearchAzizi Ghanbari et al. Original Article Adiponectin in coronary heart disease and newly diagnosed impaired glucose tolerance Diabetes

More information